Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
about
IPEX as a result of mutations in FOXP3Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunitySubcellular localization of FOXP3 in human regulatory and nonregulatory T cellsThe role of the CD58 locus in multiple sclerosisInducing and Administering Tregs to Treat Human DiseaseFOXP3: genetic and epigenetic implications for autoimmunityCentral role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gutStructure of a Domain-Swapped FOXP3 Dimer on DNA and Its Function in Regulatory T CellsFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesGenetics, pathogenesis and clinical interventions in type 1 diabetesDifferential responses of human regulatory T cells (Treg) and effector T cells to rapamycinAAV2/8-humanFOXP3 gene therapy shows robust anti-atherosclerosis efficacy in LDLR-KO mice on high cholesterol dietA remarkable depletion of both naïve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain.Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cellsAdaptive autoimmunity and Foxp3-based immunoregulation in zebrafishMechanisms of inflammatory responses in obese adipose tissue.Immunologic endocrine disorders.Regulatory T Cells in Allergy and Asthma.Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune HomeostasisImmune phenotype predicts risk for posttransplantation squamous cell carcinoma.Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis.Helminths in the gastrointestinal tract as modulators of immunity and pathology.T regulatory cells are markers of disease activity in multiple sclerosis patientsRegulatory T cells and their roles in immune dysregulation and allergy.Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus.From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation.FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.Exome sequencing identifies a novel FOXP3 mutation in a 2-generation family with inflammatory bowel disease.Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease.Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome.Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques.Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth.CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers gameTherapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.Promiscuous Foxp3-cre activity reveals a differential requirement for CD28 in Foxp3⁺ and Foxp3⁻ T cellsGene/cell therapy approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-linked syndrome.CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosisFatal autoimmunity in mice reconstituted with human hematopoietic stem cells encoding defective FOXP3Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome.
P2860
Q21342967-3FDE42FD-3F9C-4429-923F-42C545D53275Q24317691-9B911D82-210B-4B2B-B7B1-5CE86CADB55FQ24337573-F71EE535-D9C9-475D-BC15-0A22EBCCC78FQ24649291-7F9C844D-3904-442E-B08E-E91D70BA99F1Q26772723-21D01CBE-1D09-462D-BCE5-C2FCE4414FFAQ27003398-F383DB5A-D3D5-4814-84A5-123B6BEEBA2EQ27025911-C84E98C1-33B4-4FE2-933B-B47D14F03B0DQ27667400-414BEABA-E747-48F1-A7B5-6B041FAECEC3Q28076919-D17C5336-9FE1-469F-976E-6BFC42FBEF57Q28281029-93C1524E-EF63-4E2E-BC0C-13C0532A1D2CQ28475626-1657313F-873A-41D7-9D57-D92D2B90A333Q28646884-DAE9767C-741A-44F2-B115-CE28465CA29CQ33379659-352B5A1E-AEAE-4053-B236-0BE3D3F480E5Q33506644-634435F9-85D8-4046-AAE8-C5DD0ECDF114Q33539782-8DC7B140-D9F7-4B99-8E0C-8D80D073BF20Q33699810-B227CC61-D682-4FDA-8C97-910AC8F1585AQ33714100-82091FC4-D1C9-41B3-9908-000C5F1D0545Q33715605-C2966D0D-F089-44E0-BE56-7ED1FEBF1372Q33729446-0665C19D-AFDD-4913-B6DB-B285090AE3F3Q33748547-B8826D63-F2F1-4567-843D-45FC8106F12EQ33750667-ABBD433D-3D6F-4D4E-9B27-9E5B6D92C522Q33811669-76B04347-A575-4BBE-A8A9-15AB7FF0DD7FQ33867430-A3F98ACE-1772-4DC8-B818-E0BA0F17527AQ33952389-E5F60CCA-9E1B-4900-A715-5608163B0A98Q34166571-04588070-EDF5-4E13-A66A-20BCF4BD59A7Q34193132-9C94D000-D0CF-4429-B5DE-B89F48CC6566Q34515848-FF7C66C7-449B-4397-B14D-38A633CD2510Q34643537-2FFA2AC2-3BDA-48BB-AB21-EC974486B3AEQ34778685-CDD6527F-EF58-42DB-82B6-1A3103355DC6Q34813567-419142F4-FED9-4EA6-BE87-ECF5D04656FBQ35046614-DBACA931-2FDD-4D19-8F0A-D4AAFE6FD5CAQ35069126-8DC8817A-964A-44AA-A64B-6D420468D0B2Q35102281-E757CB29-33F5-4EE0-B7AE-9CDEBE2F45EAQ35178495-48988037-830E-46A8-91E6-6587503BEA67Q35435153-790D172E-188B-4B20-8D99-D591069B2E2CQ35529334-1CB83CF4-C1AD-40A1-8FCA-42DE5D54BC7CQ35646681-A4447B0C-F379-4113-B947-4EA97136624CQ35742931-7EB7F3C2-0B6D-4BFF-8F09-553F30226426Q35757391-EBFC2DA4-0986-4F1B-9980-9EC6D8B5B317Q35859565-39E1370F-705D-4C59-93A9-EB2CD98E1E9D
P2860
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@ast
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@en
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@nl
type
label
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@ast
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@en
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@nl
prefLabel
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@ast
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@en
Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
@nl
P2093
P2860
P50
P356
P1476
Defective regulatory and effector T cell functions in patients with FOXP3 mutations
@en
P2093
Anita Lawitschka
Claudia Sartirana
Franca Dagna-Bricarelli
Lucia Perroni
Megan K Levings
Minyue Dai
Rosa Bacchetta
Sarah E Allan
Steven F Ziegler
Susanne Matthes-Martin
P2860
P304
P356
10.1172/JCI25112
P407
P577
2006-06-01T00:00:00Z